SPORT

Eisai Accelerates Progress in Oncology Research with New Data at ESMO Congress 2024

TOKYO, Sept 5, 2024 – (JCN Newswire) – Eisai Co., Ltd. announced today the presentation of research across various types of cancer from its oncology portfolio and pipeline during the European Society for Medical Oncology (ESMO) Congress 2024, which is taking place virtually and in-person in Barcelona…

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button